JAX Scientific Director Nadia Rosenthal was featured in a Nature article and podcast about scientists' efforts to solve the mystery of long-haul COVID.
New JAX research is examining long COVID using data from healthcare systems across the US as part of the National COVID Cohort Collaborative (N3C).
Read MoreDerya Unutmaz and his team have capitalized on cancer immunotherapy techniques to develop potential variant-proof treatments for COVID-19.
Read MorePeter Robinson is working with hospital systems across the U.S. to pool COVID patient data and better define the scope of the long COVID problem and…
Read MoreWith the arrival of the Omicron COVID-19 variant, we take the time to examine how it got here and what the future holds for this and…
Read More